Emergence of alveolar echinococcosis in Canada: a warning for the USA
Current Opinion in Infectious Diseases·
- DOI
- 10.1097/qco.0000000000001229
- PMID
- 42619311
- PMCID
- —
- OpenAlex
- W7203754668
- Study type
- Journal article
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The authors describe alveolar echinococcosis as an emerging, under-recognized zoonotic disease in Canada and emphasize that early recognition using Em-specific diagnostics, along with a One Health approach integrating human, veterinary, and wildlife data, is needed to reduce morbidity and mortality.
Structured evidence summary
Research question
The review synthesizes recent Canadian observations indicating an increase and epidemiologic shift in locally acquired human alveolar echinococcosis in North America, and considers implications for clinical awareness.
Study design
A narrative review (article type: journal-article) summarizing recent data on human alveolar echinococcosis cases in Canada.
Population and setting
Human cases of locally acquired alveolar echinococcosis identified in Canada since 2013, frequently involving incidentally detected hepatic masses and exposures such as dog ownership and rural settings.
Main findings
Since 2013, an increasing number of Canadian alveolar echinococcosis cases have been identified, often incidentally as hepatic masses. Reported contributory factors include establishment of a European-like Echinococcus multilocularis haplotype in wildlife and domestic dogs, high peri-urban coyote density and infection prevalence, and rising clinician awareness. Diagnosis relies primarily on histopathology, supported by serology and nucleic acid amplification testing; management involves multidisciplinary care, resection when feasible, and long-term albendazole.
Public-health relevance
The authors describe alveolar echinococcosis as an emerging, under-recognized zoonotic disease in Canada and emphasize that early recognition using Em-specific diagnostics, along with a One Health approach integrating human, veterinary, and wildlife data, is needed to reduce morbidity and mortality.
Important limitations
This summary is limited to the supplied single-article abstract/metadata and requires the original paper for decision-grade interpretation. The abstract is framed as a narrative review, and no explicit limitations are stated in the provided material.
GIDS interpretation
Discoverability context only: the paper is indexed under the disease term Echinococcosis and tagged with Canada, the United States, and topics including Treatment and One Health, which would aid retrieval by clinicians, veterinarians, and public-health professionals searching for evidence on this zoonosis. No connection to any live surveillance signal is made.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 8 auditable classifier relationships to diseases, places, topics, and study design.